Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oklahoma Healthcare Wire.
Press releases published on May 6, 2025
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
GlobeNewswire
·
May 6, 2025
WALTHAM, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will participate in the following May investor conferences: BofA Securities 2025 Healthcare Conference: Fireside chat on Tuesday, …
Blue Point Brewing Co. Announces the Return of Delayed Pilsner
GlobeNewswire
·
May 6, 2025
PATCHOGUE, N.Y., May 06, 2025 (GLOBE NEWSWIRE) -- Blue Point Brewing Co., a Tilray Brands, Inc., (NASDAQ: TLRY and TSX: TLRY) craft beer brand, announces the highly anticipated re-release of Delayed Pilsner, a beer crafted to soothe the soul of every New …
TScan Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 6, 2025
Updates from the PLEXI-T™ solid tumor and ALLOHA™ heme Phase 1 clinical trials anticipated by end of year On-track to file IND application for TSC-102-A0301 (CD45; HLA-A*03:01) to FDA in the second half of the year Appointed commercial leader Stephen …
Vantage Hemp Co. Submits Application for Brazil Market Entry
GlobeNewswire
·
May 6, 2025
Greeley, Colorado, May 06, 2025 (GLOBE NEWSWIRE) -- Vantage Hemp Co. (“Vantage” or “the Company”), a globally accredited cannabinoid extractor and manufacturer, has initiated its regulatory process with ANVISA, Brazil’s National Health Surveillance Agency, …
Transpire Bio Announces R&D and Manufacturing Expansion
GlobeNewswire
·
May 6, 2025
SUNRISE, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announced that it has signed an agreement to expand …
Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs
GlobeNewswire
·
May 6, 2025
– Top-line data from Phase 2 clinical trial of verekitug in patients with chronic rhinosinusitis with nasal polyps expected in the third quarter of 2025 – – Top-line data from Phase 2 clinical trial of verekitug in patients with severe asthma now expected …
Advanced Aesthetics Plastic Surgery Partners with Ascend Aesthetic Partners to Strengthen a Collaborative Community Focused on Growth, Learning, and Patient Care
GlobeNewswire
·
May 6, 2025
ATLANTA, May 06, 2025 (GLOBE NEWSWIRE) -- Advanced Aesthetics Plastic Surgery has joined Ascend Aesthetic Partners, forming a partnership rooted in shared values of collaboration, clinical excellence, and continuous learning. With the addition of Dr. …
Tiziana Life Sciences Announces Comprehensive Positive Results from Study of Nasal Foralumab in Patients with Multiple Sclerosis
GlobeNewswire
·
May 6, 2025
Meaningful Fatigue score reduction seen in study is a critically important quality of life (QoL) measure for Multiple Sclerosis patients. All patients experienced stabilization of Expanded Disability Status Scale (EDSS) scores. TSPO-PET imaging showed …
Sharps Technology Receives ~$100K Initial Purchase Order from Hungarian Vaccine Provider for SecureGard™ Syringes
GlobeNewswire
·
May 6, 2025
Sharps also received an initial qualification purchase order for DisGard™ single-use Sharps Recovery System Company transitions to revenue producing with second purchase order, bringing total recent orders to approximately $500,000 for the quarter NEW YORK …
Slimjaro Under Review : Inspecting the Results of Slim jaro ingredients, Benefits, Pros and Cons! Pink Salt Trick Recipe for Weight Loss
GlobeNewswire
·
May 6, 2025
Kansas City MO, May 06, 2025 (GLOBE NEWSWIRE) -- Let's face it - we're drowning in weight loss products that promise the world but leave us high and dry. But there's a new kid on the block called Slimjaro, and it's got doctors, researchers, and real people …
Verona Pharma to Present Seven Analyses of the Phase 3 ENHANCE Studies in COPD at ATS 2025
GlobeNewswire
·
May 6, 2025
Analyses support Ohtuvayre® (ensifentrine) as a first-in-class selective dual inhibitor of PDE3 and PDE4 for a broad COPD population LONDON and RALEIGH, N.C., May 06, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona” or the “Company”), a …
CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE EXCHANGE AGREEMENT TO MAKE FITTERS SDN. BHD. ITS WHOLLY-OWNED SUBSIDIARY TO ACCELERATE GROWTH AND STOCKHOLDER VALUE
GlobeNewswire
·
May 6, 2025
KUALA LUMPUR, MALAYSIA, May 06, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”) today announced that it entered into an Exchange Agreement with FITTERS Diversified Berhad (9318.KL; “FITTERS …
The 4 Best Male Enhancement Pills to Buy OTC, In Stores & Online 2025: Top Sex Pills for Men's Sexual Performance Over the Counter - Leading Edge Health
GlobeNewswire
·
May 6, 2025
Limassol, Cyprus, May 06, 2025 (GLOBE NEWSWIRE) -- The top male enhancement pills for 2025 is presented by Leading Edge Health Finding the best male enhancement pill can feel overwhelming with so many options available over the counter, in stores, and …
ProstaVive Side Effects & Complaints EXPOSED: Real Review Backed by ProstaVive Users’ Experiences!
GlobeNewswire
·
May 6, 2025
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Thinking about trying ProstaVive to support your prostate health, energy, and overall wellness? You're definitely not alone. This natural supplement has been generating a lot of buzz, and it’s easy to see why. …
Mind Lab PRO Under Review: Is Mind Lab Pro® v4.0 Universal Nootropic Brain Booster Safe? Best Nootropics Supplement
GlobeNewswire
·
May 6, 2025
Royal Leamington Spa, May 06, 2025 (GLOBE NEWSWIRE) -- Mind Lab Pro is a nootropic pill containing relatively high concentrations of eleven distinct nootropic substances. It promises to help the following: Focus Energy Mood’s Calmness Memory Clarity …
Italfarmaco Announces U.S. FDA Grants Fast Track Designation to Givinostat in Treatment of Polycythemia Vera
GlobeNewswire
·
May 6, 2025
MILAN, Italy, May 6, 2025 – Italfarmaco S.p.A. announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to givinostat for the treatment of patients with polycythemia vera (PV), a rare haematologic cancer, for …
ENA Respiratory Appoints International Pharma Experts as Strategic Advisors to Support Development of INNA-051 Antiviral Host Defence Enhancer
GlobeNewswire
·
May 6, 2025
MELBOURNE, Australia, May 06, 2025 (GLOBE NEWSWIRE) -- ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence enhancers to minimize the impact of viral respiratory infections, announces today that it has appointed Kenny …
Microbiotica unveils multiple mechanisms by which MB310, in clinical development for the treatment of ulcerative colitis, protects the intestinal barrier
GlobeNewswire
·
May 6, 2025
CAMBRIDGE, United Kingdom, May 06, 2025 (GLOBE NEWSWIRE) -- Microbiotica, a clinical-stage biopharma Company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), has presented new data on the mechanism of …
Essential Pharma strengthens management team with appointment of Duncan Ferguson as Vice President, Commercial
GlobeNewswire
·
May 6, 2025
Egham, UK – 6th May 2025 – Essential Pharma (“Essential” or “the Company”), a global pharmaceutical company developing and delivering medicines for patients in niche populations, today announces the appointment of Duncan Ferguson as Vice President, …
Priothera Appoints Dr. Jens Hasskarl as Chief Medical Officer to Drive Late-Stage Clinical Development of Mocravimod, a S1P Receptor Modulator for Acute Myeloid Leukemia (AML)
GlobeNewswire
·
May 6, 2025
Dr. Hasskarl to lead global Phase 3 MO-TRANS study evaluating mocravimod as an adjunctive treatment to allo-HCT in AML Saint-Louis, France and Dublin, Ireland – 6th May 2025– Priothera Ltd., a late-stage biopharma company pioneering the development of …